Literature DB >> 2390245

The management of metastases to eye and orbit from carcinoma of the breast.

B H Burmeister1, C S Benjamin, W J Childs.   

Abstract

This report describes 11 patients who developed visual symptoms due to choroidal or orbital metastases from carcinoma of the breast. All patients were treated using palliative radiotherapy with regression of metastases in five of six patients (83%) having choroidal involvement and three of five patients (60%) having orbital metastases. There were no complications due to radiotherapy. All these patients had advanced metastatic breast cancer with poor survival following development of orbital or choroidal metastases.

Entities:  

Mesh:

Year:  1990        PMID: 2390245     DOI: 10.1111/j.1442-9071.1990.tb00612.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  5 in total

1.  Orbital metastases: diagnosis and course.

Authors:  D H Char; T Miller; S Kroll
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  Bilateral orbital metastases in a woman with breast carcinoma.

Authors:  H J Zambarakji; P R Simcock; P E Kinnear
Journal:  J R Soc Med       Date:  1997-12       Impact factor: 5.344

3.  Non-small cell lung cancer presenting with choroidal metastasis as first sign and showing good response to chemotherapy alone: a case report.

Authors:  Abhishek Singh; Parul Singh; Kamal Sahni; Preety Shukla; Vikas Shukla; Nirdosh K Pant
Journal:  J Med Case Rep       Date:  2010-06-19

Review 4.  Orbital metastases in breast cancer: report of two cases and review of the literature.

Authors:  A Dieing; C-O Schulz; P Schmid; A C Roever; S Lehenbauer-Dehm; C Jehn; B Flath; K Possinger
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-07       Impact factor: 4.553

5.  Lateral rectus metastasis from an occult systemic malignancy masquerading as abducens palsy: a case report.

Authors:  Mohammad T Masoud; Ajmal Rehman; Yusuf Shaikh
Journal:  J Med Case Rep       Date:  2008-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.